BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36587172)

  • 21. The role of spleen radiomics model for predicting prognosis in esophageal squamous cell carcinoma patients receiving definitive radiotherapy.
    Guo L; Liu A; Geng X; Zhao Z; Nie Y; Wang L; Liu D; Li Y; Li Y; Li D; Wang Q; Li Z; Liu X; Li M
    Thorac Cancer; 2024 Apr; 15(12):947-964. PubMed ID: 38480505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Radiomics Nomogram for Non-Invasive Prediction of Progression-Free Survival in Esophageal Squamous Cell Carcinoma.
    Yan T; Liu L; Yan Z; Peng M; Wang Q; Zhang S; Wang L; Zhuang X; Liu H; Ma Y; Wang B; Cui Y
    Front Comput Neurosci; 2022; 16():885091. PubMed ID: 35651590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery.
    Qiu Q; Duan J; Deng H; Han Z; Gu J; Yue NJ; Yin Y
    Front Oncol; 2020; 10():1398. PubMed ID: 32850451
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognostic nomogram integrated systemic inflammation score for patients with esophageal squamous cell carcinoma undergoing radical esophagectomy.
    Shao Y; Ning Z; Chen J; Geng Y; Gu W; Huang J; Pei H; Shen Y; Jiang J
    Sci Rep; 2015 Dec; 5():18811. PubMed ID: 26689680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-enhanced CT radiomics features to predict recurrence of locally advanced oesophageal squamous cell cancer within 2 years after trimodal therapy: A case-control study.
    Tang S; Ou J; Wu YP; Li R; Chen TW; Zhang XM
    Medicine (Baltimore); 2021 Jul; 100(27):e26557. PubMed ID: 34232198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
    Chen J; Xia YJ; Liu TY; Lai YH; Yu JS; Zhang TH; Ooi S; He YL
    BMC Cancer; 2021 May; 21(1):532. PubMed ID: 33971833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
    Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
    World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy.
    Duan J; Xie Y; Qu L; Wang L; Zhou S; Wang Y; Fan Z; Yang S; Jiao S
    J Immunother Cancer; 2018 Oct; 6(1):100. PubMed ID: 30285868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Nutrition and Inflammation-Related Nomogram to Predict Overall Survival in Surgically Resected Esophageal Squamous Cell Carcinoma (ESCC) Patients.
    Li J; Mei X; Sun D; Guo M; Xie M; Chen X
    Nutr Cancer; 2022; 74(5):1625-1635. PubMed ID: 34369223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity of T3 stage esophageal squamous cell carcinoma in different parts based on enhanced CT radiomics.
    Li XF; Wang Q; Duan SF; Yao B; Liu CY
    Medicine (Baltimore); 2020 Aug; 99(32):e21470. PubMed ID: 32769880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nomograms to predict survival rates for esophageal cancer patients with malignant behaviors based on ICD-0-3.
    Sun Y; Wang J; Li Y; Pan S; Yang T; Sun X; Wang Y; Shi X; Zhao X; Zhang X
    Future Oncol; 2019 Jan; 15(2):121-132. PubMed ID: 30232909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decoding tumor stage by peritumoral and intratumoral radiomics in resectable esophageal squamous cell carcinoma.
    Tan XZ; Ma R; Liu P; Xiao CH; Zhang HH; Yang F; Liang CH; Liu ZY
    Abdom Radiol (NY); 2024 Jan; 49(1):301-311. PubMed ID: 37831168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
    Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
    Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomogram based on immune scores for predicting the survival of patients with esophageal squamous cell carcinoma.
    Wu W; Ma W; Li D; Zheng S; Zhao F; Feng X; Lyu J
    J Int Med Res; 2021 Apr; 49(4):3000605211009697. PubMed ID: 33900866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor SUVs on 18F-FDG PET/CT and Aggressive Pathological Features in Esophageal Squamous Cell Carcinoma.
    Lim CH; Park YJ; Shin M; Cho YS; Choi JY; Lee KH; Hyun SH
    Clin Nucl Med; 2020 Mar; 45(3):e128-e133. PubMed ID: 31977480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiomics nomogram outperforms size criteria in discriminating lymph node metastasis in resectable esophageal squamous cell carcinoma.
    Tan X; Ma Z; Yan L; Ye W; Liu Z; Liang C
    Eur Radiol; 2019 Jan; 29(1):392-400. PubMed ID: 29922924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
    Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G
    Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma.
    Zhang B; Tian J; Dong D; Gu D; Dong Y; Zhang L; Lian Z; Liu J; Luo X; Pei S; Mo X; Huang W; Ouyang F; Guo B; Liang L; Chen W; Liang C; Zhang S
    Clin Cancer Res; 2017 Aug; 23(15):4259-4269. PubMed ID: 28280088
    [No Abstract]   [Full Text] [Related]  

  • 40. A six-microRNA risk score model predicts prognosis in esophageal squamous cell carcinoma.
    Mao Y; Fu Z; Zhang Y; Dong L; Zhang Y; Zhang Q; Li X; Wang C
    J Cell Physiol; 2019 May; 234(5):6810-6819. PubMed ID: 30387125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.